We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Willful Patent Infringement Claims Dismissed In New York

Mealey's (October 26, 2018, 11:05 AM EDT) -- NEW YORK — A New York federal judge on Oct. 24 found that allegations of willful infringement levied in connection with patented gene expression technology fail to state a claim (Novartis...
To view the full article, register now.